U.S. states move to expand generic drug price-fixing lawsuit

WASHINGTON (Reuters) – A large group of U.S. state attorneys general on Tuesday sought to expand a lawsuit alleging price fixing of generic drugs to 18 companies and 15 medicines on Tuesday, including Novartis AG’s generic unit Sandoz and India-based Sun Pharmaceutical Industries Ltd .


Source: Reuters Health